Noradrenergic α1 Receptors as a Novel Target for the Treatment of Nicotine Addiction

Correction to: Neuropsychopharmacology advance online publication, 31 March 2010; doi:10.1038/npp.2010.42

In this article, the data below Table 2 are incorrect. Table 2 is republished here with the correct data.

Table 2. Response Rates of Rats During the Drug Discrimination Study at Different Nicotine Doses (0–0.4 mg/kg) After Prazosin (0–1 mg/kg) Pretreatment.

	Nicotine dose (mg/kg)
	0	0.01	0.03	0.1	0.3	0.4
Vehicle	2.1±0.3	1.9±0.2	2±0.3	2±0.2	2.2±0.2	2±0.3
Prazosin 0.25 mg/kg	1.8±0.2	1.7±0.3	1.7±0.2	1.9±0.2	2.3±0.2	1.5±0.3
Prazosin 0.5 mg/kg	2±0.2	1.3±0.2	1.7±0.2	1.6±0.2	1.8±0.3	1.7±0.3
Prazosin 1 mg/kg	1.7±0.2	1.7±0.1	2±0.3	1.8±0.2	2±0.2	1.6±0.2
ANOVA F33,3=	1.7, NS	1.75, NS	1.95, NS	1.3, NS	1.4, NS	1.3, NS

Data are expressed as rate of responding on levers (in lever presses/sec±SEM).